BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9934572)

  • 1. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis.
    Daif AK
    Funct Neurol; 1998; 13(4):285-9. PubMed ID: 9934572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticardiolopin antibodies as a risk factor in stroke].
    Krześniak-Bohdan M; Dobrzyńska L; Bakowska A; Banecka-Majkutewicz Z
    Wiad Lek; 1998; 51(9-10):414-8. PubMed ID: 9921104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Iacob SA
    Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrence and prognosis in ischemic stroke patients with anticardiolipin antibody in Japan].
    Kitagawa Y; Shinohara Y; Niwa K; Yoshitoshi M; Kametsu Y
    Rinsho Shinkeigaku; 1994 Aug; 34(8):799-804. PubMed ID: 7994987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticardiolipin-antibodies in stroke and in other neurological disorders.
    Perju-Dumbrava L; Zeiler K; Kapiotis S; Deecke L
    Rom J Neurol Psychiatry; 1995; 33(2):137-43. PubMed ID: 7547377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
    Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
    Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
    Ali HY; Abdullah ZA
    J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan.
    Lien LM; Chen WH; Chiu HC; Pan WH; Chen JR; Bai CH
    Cerebrovasc Dis; 2006; 22(4):225-30. PubMed ID: 16788294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients.
    Tănăsescu R; Ticmeanu M; Nicolau A; Uscătescu V; Cojocaru M; Grecu V; Serbănescu A
    Rom J Intern Med; 2005; 43(1-2):79-88. PubMed ID: 16739868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG anti-cardiolipin antibodies-markers of inflammation in diabetic patients with ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
    Rom J Intern Med; 2003; 41(3):277-81. PubMed ID: 15526511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antiphospholipid antibodies in young women with ischemic stroke.
    Cojocaru IM; Cojocaru M; Burcin C; Atanasiu A
    Rom J Intern Med; 2007; 45(2):201-4. PubMed ID: 18333375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin antibodies in ischemic stroke in the young: Indian experience.
    Nagaraja D; Christopher R; Manjari T
    J Neurol Sci; 1997 Sep; 150(2):137-42. PubMed ID: 9268241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are the anticardiolipin antibodies a risk factor for coronary artery disease in chronic renal failure patients?
    Ucar E; Kuvandik G; Sert M; Kuvandik C; Temizkan A; Borazan A
    Ren Fail; 2008; 30(8):791-5. PubMed ID: 18791953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
    Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
    Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin antibodies in patients with liver disease.
    Mangia A; Margaglione M; Cascavilla I; Gentile R; Cappucci G; Facciorusso D; Grandone E; Di Minno G; Rizzetto M; Andriulli A
    Am J Gastroenterol; 1999 Oct; 94(10):2983-7. PubMed ID: 10520856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticardiolipin antibodies in patients with cerebral vascular accident].
    Soares M; Morais MF; Soares I; Pinheiro N; Nunes AR; Aguiar P; Abecasis P
    Rev Port Cardiol; 1998 Jun; 17(6):525-30. PubMed ID: 9677830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibody positive young stroke: an analysis of 12 cases.
    Panagariya A; Garg A; Sureka RK
    J Postgrad Med; 2000; 46(4):258-61. PubMed ID: 11435651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.